Skip to content

Lymph node mapping for determination of optimum lymph node dissection for surgical treatment of colorectal cancer

Lymph node mapping for determination of optimum lymph node dissection for surgical treatment of colorectal cancer - Lymph node mapping for determination of optimum lymph node dissection for surgical treatment of colorectal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000028815
Enrollment
100
Registered
2017-09-06
Start date
2017-09-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

None listed

Sponsors

Fukuoka University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Primary colon cancer patient diagnosed histologically as adenocarcinoma. Preoperative StageII-IV Colorectal Cancer Patient.

Exclusion criteria

Exclusion criteria: Have double cancer. However, only for metachronous double cancer with a disease-free period longer than 5 years, registration is permitted. Those with a history of operation affecting the colorectal cancer operation. Those with a history of hypersensitivity to ICG and iodine.

Design outcomes

Primary

MeasureTime frame
Evaluation of extent of lymph node metastasis (distance in axial direction of the intestinal tract, relationship with feeding vessel, central side)

Countries

Japan

Contacts

Public ContactRyohei Sakamoto

Fukuoka University School of Medicine Gastroenterological surgery

skmt19790907@fukuoka-u.ac.jp092-801-1101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026